Search

Search Results

Results 6371 - 6380 of 6900 for A-fil

Terimide

Drug - 18 May 2026

Consumer Medicine Information (CMI) about Terimide intended for persons living in Australia.
High-throughput chromatography in bioprocess analytics

White Paper - 30 Apr 2026

Understand bioprocess analytics with high-throughput chromatography optimization.
Inside the high-stakes corporate fight over feeding preterm babies

News - 30 Mar 2026

In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company's profits and the lives of some of the world's most fragile people: preterm infants.
What is Decision Fatigue and How Does it Affect Your Brain and Daily Choices?

Health - 23 Mar 2026

As modern life demands thousands of daily choices, emerging research reveals how cumulative decision-making reshapes brain networks, weakens judgment, and subtly shifts behavior toward easier, but...
Vaxelis

Drug - 4 Mar 2026

Consumer Medicine Information (CMI) about Vaxelis intended for persons living in Australia.
Abrysvo

Drug - 23 Feb 2026

Consumer Medicine Information (CMI) about Abrysvo intended for persons living in Australia.
Cryo-preservation for life saving research

White Paper - 27 Jan 2026

Anthony Nolan is a leading stem cell charity, using cryo-preservation as part of research across biotech and pharma.
NovoMix 30 FlexPen

Drug - 13 Jan 2026

Consumer Medicine Information (CMI) about NovoMix 30 FlexPen intended for persons living in Australia.
Levemir FlexPen

Drug - 12 Dec 2025

Consumer Medicine Information (CMI) about Levemir FlexPen intended for persons living in Australia.
Reminyl

Drug - 14 Nov 2025

Consumer Medicine Information (CMI) about Reminyl intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.